Scaling up HCV testing, treatment in prisons highly cost-effective

Scaling up hepatitis C testing and treatment in prisons effectively reduced HCV incidence and was a cost-effective option compared with existing services, data from a study in Australian prisons showed.
“There is a disproportionately high HCV prevalence in people who inject drugs in correctional settings, estimated at 15% of the 10 million people who are incarcerated at any one time worldwide,” Sophy T.F. Shih, DrPH, a senior health economist at the Kirby Institute of University of New South Wales, and colleagues wrote. “The Surveillance and Treatment of Prisoners with

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart